Seth Malmersjö

Title: Seth Malmersjö: Innovator in ILT3-Binding Agents

Introduction

Seth Malmersjö is a notable inventor based in Menlo Park, CA. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of ILT3-binding agents. With a total of 2 patents, his work is paving the way for advancements in therapeutic applications.

Latest Patents

Seth's latest patents focus on ILT3-binding agents and methods of use thereof. The present disclosure provides binding agents, such as antibodies, that specifically bind ILT3, including human ILT3. It also includes compositions comprising these binding agents and methods of their use. Additionally, the disclosure provides related polynucleotides and vectors encoding the binding agents, as well as cells comprising the binding agents.

Career Highlights

Seth is currently employed at NGM Biopharmaceuticals, Inc., where he continues to innovate in the biopharmaceutical sector. His work is instrumental in developing new therapeutic strategies that leverage the unique properties of ILT3-binding agents.

Collaborations

Seth collaborates with talented individuals in his field, including Betty Chan Li and Daniel David Kaplan. These partnerships enhance the research and development efforts at NGM Biopharmaceuticals, Inc.

Conclusion

Seth Malmersjö is a prominent figure in the biopharmaceutical industry, with a focus on ILT3-binding agents. His contributions are vital for the advancement of therapeutic solutions, and his ongoing work promises to yield significant benefits in the field.